Taken together, your cardiovascular markers place you in a generally stable zone, yet they hint at early shifts in circulatory tone and electrical activity that merit awareness. The systolic blood pressure of 126 mmHg sits in the high-normal bracket, while the diastolic value of 68 mmHg remains comfortably mid-range, creating a widened pulse pressure that may reflect stiffer arteries or increased stroke volume rather than frank hypertension. An 86 bpm resting heart rate is slightly above the mid-60s to low-70s range often associated with lower cardiac workload, and when paired with the normal-length QT interval of 398 ms, it shows your cardiac conduction system is keeping pace without prolongation but is being driven a bit faster than ideal. The combined picture—marginally elevated systolic pressure, normal diastolic pressure, and mildly accelerated pulse—suggests your heart is pushing blood effectively but encountering a modest uptick in vascular resistance or sympathetic drive; over time, such a pattern can progress toward sustained hypertension if lifestyle or stress factors remain unchanged. A noteworthy nuance is that the preserved QT interval despite the higher heart rate points to good autonomic balance at the myocardial level, indicating that current electrical stability is intact even as hemodynamic demand rises.

[ID: 1931b4e7-5f08-4619-8727-d832b70b7014] Systolic Blood Pressure [Quantitative]

*Systolic Blood Pressure [Quantitative] measurements (34 data points) - Cardiovascular*

- Overview: Systolic blood pressure is the peak pressure exerted on artery walls when the heart contracts, reflecting how hard the heart must work to pump blood through the body. - Measurements: Twelve readings taken during the same month span from 100 mmHg to 133 mmHg; eight values sit in the normal range (<120 mmHg), two are in the elevated range (120–129 mmHg), and two reach the stage-1 hypertension zone (130–139 mmHg). - Trend: Variable; all results occur in a single month, so no longitudinal direction can be determined, but day-to-day variability of 33 mmHg indicates inconsistent control. - Clinical Meaning: An average of about 117 mmHg is comfortably within the normal range, suggesting overall healthy pressure; however, intermittent spikes to 132–133 mmHg show periods where the heart and vessels experience higher strain, potentially signaling early blood-pressure reactivity to stress, activity, diet, or measurement conditions. Readings down at 100 mmHg are still normal but widen the variability window, making it harder to know your true baseline. Large swings like this can be a marker of increased cardiovascular risk over time even when the mean value is normal. - Action: Continue monitoring at consistent times and conditions to determine a stable baseline; aim for most readings below 120 mmHg to minimize long-term cardiovascular risk; note lifestyle factors (caffeine, salt, exercise, stress) surrounding higher values and adjust as needed; if repeated measurements continue to exceed 130 mmHg, share the pattern with your healthcare provider for further evaluation; current average is favorable, so maintaining balanced diet, regular activity, and stress-management habits should help keep pressures in the optimal zone.

[ID: 3ee16365-2ef7-44f9-b27c-95d88d6539bd] Pulse Rate [Quantitative]

*Pulse Rate [Quantitative] measurements (35 data points) - Cardiovascular*

- Overview: Pulse rate counts how many times the heart beats in one minute, reflecting how hard and fast the heart is working at the moment of measurement. - Measurements: Across twelve readings taken in September 2025, results ranged from 51 bpm to 93 bpm; the average was about 70 bpm. Half of the values (61–84 bpm) sat in the mid-range, four readings were on the lower side (51–58 bpm), and one reading reached the upper end (93 bpm). - Trend: Because all data come from the same month, no long-term direction can be determined; within that short window the pattern is variable rather than steadily rising or falling. - Clinical Meaning: A resting adult pulse typically falls between 60 and 100 bpm. • Readings of 61–84 bpm align with this expected range and suggest the heart was functioning normally at those moments. • Values below 60 bpm (51–58 bpm) can occur in well-conditioned individuals or during relaxation but may also appear with certain medications, low thyroid activity, or dehydration; they signal slower cardiac pacing but are not automatically harmful. • The single 93 bpm result approaches the upper normal limit; temporary elevation often reflects recent activity, stress, fever, or caffeine rather than disease. The coexistence of lower and higher readings in close proximity implies that the measurements were taken under differing circumstances (e.g., rest vs. movement) rather than a pathological swing. Overall, the average of 70 bpm points to a generally healthy cardiac rhythm with intermittent expected fluctuations. - Action: Continue recording pulse under similar conditions—preferably first thing in the morning after a few minutes of rest—to create a clearer, comparable trend. Note factors such as exercise, emotional stress, illness, caffeine, or medication at each reading to explain deviations. If consistently below 50 bpm with symptoms (fatigue, dizziness) or above 100 bpm at rest, share the log with a healthcare provider; otherwise, current values appear broadly normal and no immediate changes are required.

[ID: 506b12d1-0a67-49b1-97a7-7c5dffb4f7e1] Diastolic Blood Pressure [Quantitative]

*Diastolic Blood Pressure [Quantitative] measurements (28 data points) - Cardiovascular*

- Overview: Diastolic blood pressure measures the force that blood exerts against artery walls when the heart relaxes between beats. - Measurements: Twelve readings taken in September 2025 ranged from 62 mmHg to 86 mmHg; six values fell between 62-79 mmHg and six values were between 81-86 mmHg. - Trend: Variable; all results were collected within the same month, showing alternating lower-normal and mildly elevated numbers without a consistent upward or downward direction. - Clinical Meaning: Readings in the low-to-mid 60s sit at the lower end of the typical healthy spectrum, while values in the 70s are generally considered normal; numbers above 80 mmHg often signal the beginning of diastolic hypertension. Having roughly half of the measurements at or above 81 mmHg suggests intermittent elevation that could, if persistent, increase long-term risk for heart attack, stroke, and kidney strain. The 24 mmHg swing between lowest and highest readings indicates blood-pressure lability, which may reflect factors such as time of day, recent activity, stress, caffeine, medication timing, or cuff placement rather than a stable underlying condition. - Action: Continue recording blood-pressure readings at the same time each day, seated and rested for five minutes, to confirm whether elevations persist. If repeated values stay below 80 mmHg, current status is generally viewed as optimal. If several future readings remain at or above 80-85 mmHg, discuss with a healthcare professional about lifestyle measures—salt reduction, regular aerobic exercise, weight management, moderating alcohol, and stress-reduction techniques—or medication review. Bring a log of home and clinic measurements to any appointment so decisions can be based on a fuller picture rather than isolated results.

[ID: c21fcd8a-1b0a-432d-838d-74613d3cb1fc] Qt Interval [Quantitative]

*Qt Interval [Quantitative] measurements (3 data points) - Cardiovascular*

- Overview: The QT interval on an electrocardiogram represents how long the lower chambers of the heart take to contract and reset for the next beat. - Measurements: April 2024 reading was 387 ms; July 2024 showed three identical readings of 398 ms. One corrected QT (QTc) value from April 2024 was 417 ms; no further QTc values were recorded. - Trend: Slight upward shift of 11 ms between April and July, but overall values remain tightly clustered, indicating a generally stable pattern rather than a clear deterioration or improvement. - Clinical Meaning: Typical resting QT intervals for adults are roughly 350–440 ms, and QTc values are usually considered normal below about 450 ms for males and 470 ms for females. All recorded QT (387-398 ms) and the single QTc (417 ms) readings fall within these commonly cited limits, suggesting no evident QT prolongation that would raise concerns about rhythm instability or risk of dangerous arrhythmias under usual circumstances. The consistent values across multiple July recordings reinforce that the measurement is reproducible rather than a one-off anomaly. - Action: Maintain periodic ECG monitoring, especially if new medications, electrolyte disturbances, or symptoms such as palpitations occur, as these can influence the QT interval. If future readings begin to exceed established normal limits or vary widely, discuss with a healthcare professional; otherwise, current values appear within a typical healthy range.

Most measures fall inside their reference ranges, outlining generally stable blood health with adequate oxygen-carrying capacity and balanced immune defence. The one clear deviation is a reduced red blood cell count of 4.4 ×10^12/L; yet hemoglobin (13.7 g/dL) and hematocrit (42 %) remain normal, indicating that each red cell is well supplied with hemoglobin and compensates for the lower cell number. Low-edge totals for white blood cells (4.4 ×10^9/L), neutrophils (2.1 ×10^9/L; 47 %), and platelets (157 ×10^9/L) cluster together, creating a pattern of mildly diminished marrow output, while a high-normal lymphocyte percentage of 43.1 % reflects a relative shift in the differential rather than an absolute excess. Overall, the data suggest a resilient hematologic system operating near its lower reserve, with the noteworthy insight that oxygen delivery is preserved by richer hemoglobin content per red cell despite their reduced count.

[ID: 8452adcf-b9e9-4e70-a315-e11b2a7566bd] Eosinophil Absolute Count [In Blood - Quantitative]

*Eosinophil Absolute Count [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: The eosinophil absolute count measures how many eosinophil white blood cells are present in a given volume of blood, reflecting part of the body’s immune and allergic-response activity. - Measurements: In May 2025 the count was 0.03 ×10^9/L, slightly below that lab’s reference range (0.04–0.4). Six months later, in Nov 2025, it rose to 0.10 ×10^9/L, well inside the reference range (0.0–0.7) used for that test. - Trend: With only two data points, the direction appears improving; the value moved from mildly low to solidly normal and stayed within normal limits at the latest check, suggesting favorable change rather than random fluctuation. - Clinical Meaning: A mildly low eosinophil count can be seen after acute stress, with certain medications (e.g., corticosteroids), or simply as normal day-to-day variation; very low levels rarely cause symptoms. The later normalization indicates the earlier dip was likely transient and not part of a progressive decline. A count of 0.10 ×10^9/L is well within typical healthy ranges, supporting the idea that current eosinophil-related immune function is adequate. - Action: No immediate action appears necessary because the most recent result is normal. Continue routine follow-up testing at intervals recommended by the healthcare team so any future shifts can be detected. If new medications, infections, or allergic issues arise before the next scheduled lab, an earlier re-check could be considered to confirm stability.

[ID: f304ae81-c33a-4f26-bc75-a7f5e5b1e85a] Neutrophil Absolute Count [In Blood - Quantitative]

*Neutrophil Absolute Count [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: Neutrophil Absolute Count shows how many neutrophil white blood cells are circulating in each liter of blood, reflecting the body’s front-line capacity to fight bacterial infections. - Measurements: 2024-07 reading was 1.8 ×10^9/L, slightly below the 2.0–7.0 reference range; 2025-11 reading rose to 2.1 ×10^9/L, just inside the normal range. - Trend: Direction is improving, moving from mildly low to normal; with only two data points the pattern appears favorable but not yet firmly established. - Clinical Meaning: The low value in 2024 suggested temporary mild neutropenia, which can increase infection susceptibility when sustained; the subsequent normalization implies recovery of bone-marrow output or resolution of a transient suppressive factor (e.g., recent infection, medication effect, nutritional deficit). The small margin above the lower limit means the immune reserve is currently adequate but still relatively close to the threshold, so large fluctuations could re-expose risk. - Action: Continue regular blood counts (e.g., annually or sooner if illness, new medications, or unexplained fatigue/fever occur) to confirm stability; support neutrophil health through balanced nutrition (adequate protein, B12, folate), timely vaccinations, and prompt medical review if recurrent infections emerge; if future counts fall below 2.0 ×10^9/L again, discuss possible causes and targeted evaluation with a clinician.

[ID: c8be8a96-b1d0-48f6-8197-c2f6d816bb19] Red Blood Cell Count [In Blood - Quantitative]

*Red Blood Cell Count [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: The red blood cell (RBC) count tells how many oxygen-carrying cells are circulating in each liter of blood. - Measurements: 2024-07 = 4.6 ×10^12/L (within range, but at the lower limit); 2025-05 = 4.58 ×10^12/L (still within range, again near the low boundary); 2025-11 = 4.4 ×10^12/L (below the reference range, flagged low). - Trend: Gradual, consistent decline over 16 months; the count moved from just inside the normal range to slightly below it, showing a mild but steady downward trajectory rather than random fluctuation. - Clinical Meaning: A falling RBC count that ultimately drops below the reference range usually reflects reduced oxygen-carrying capacity and can signal the early stages of anemia. Possible contributors include iron or vitamin B12 deficiency, chronic low-grade blood loss (e.g., heavy menstrual bleeding, gastrointestinal issues), chronic inflammation, kidney-related hormone changes, or marrow production slow-down. Because earlier readings were already near the low threshold, even a small further decrease is enough to push the value outside the normal band, making symptoms such as fatigue, shortness of breath with exertion, or paleness more likely if the trend continues. - Action: Repeat the complete blood count in the near term to confirm whether the decline persists or stabilizes. If the value remains low, consider additional labs (hemoglobin, hematocrit, iron studies, ferritin, vitamin B12, folate, reticulocyte count) to pinpoint the cause. Review any sources of blood loss, dietary iron and B-vitamin intake, and medications that might affect blood production. Hydration does not appear to explain the downward movement, so focused evaluation is advisable. Timely follow-up with a healthcare provider can help correct reversible contributors and restore the RBC count toward the optimal zone.

[ID: 5442c1d5-6e55-4763-8cfc-0fae78a6a9f7] White Blood Cell Count [In Blood - Quantitative]

*White Blood Cell Count [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: White blood cell count indicates the quantity of immune cells in the bloodstream, giving insight into the body’s ability to fight infection and respond to inflammation. - Measurements: Two identical readings in May 2025 showed 3.8 ×10⁹/L, slightly below the laboratory reference range; a follow-up in November 2025 rose to 4.4 ×10⁹/L, now inside the normal limits. - Trend: Overall improving; values moved from low to low-normal, and the November result suggests recovery, though the count remains toward the lower end of normal and only one post-low measurement is available. - Clinical Meaning: The May results reflected mild leukopenia, which can occur after viral illnesses, medication effects, or bone marrow suppression; the return to normal by November indicates that any transient factor has likely resolved and bone marrow output is adequate. Persistently low-normal levels can still mean less reserve during infections, so recognizing new symptoms (fever, frequent infections, unusual fatigue) remains important. - Action: Continue routine complete blood counts at the next scheduled check-up or sooner if new symptoms appear; maintain balanced nutrition, adequate sleep, and stress management to support immune health; if future readings drop below 4.0 ×10⁹/L again or other blood cell lines (e.g., hemoglobin, platelets) become abnormal, discussing further evaluation with the healthcare provider would be prudent.

[ID: c8d27f17-9cfe-4494-b7d4-10df6c093d92] Basophil Absolute Count [In Blood - Quantitative]

*Basophil Absolute Count [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: Basophil Absolute Count measures the number of basophils (a type of white blood cell involved in immune and allergic responses) circulating in the blood. - Measurements: Two readings are available—both in May 2025 and November 2025 show a result of 0.0 ×10^9/L. The May result was flagged out of range (reference not provided), whereas the November result matches the stated reference interval of 0.0 – 0.1 ×10^9/L. - Trend: The values are identical across the six-month span, indicating a stable pattern without increase or decrease. - Clinical Meaning: A count of 0.0 ×10^9/L is at the extreme low end of the normal range reported in November. Persistently very low basophil numbers are often benign and may occur with normal physiological variation; however, they can also be seen during periods of acute stress, infections, or exposure to corticosteroids, all of which temporarily suppress basophils. Because both results are zero, the body’s basophil activity is currently minimal, but this alone does not confirm or exclude any specific condition. - Action: Values align with the reference range provided in November and show no worsening trend. If future tests continue to read 0.0 ×10^9/L, consider discussing with a healthcare professional to confirm the finding, review medications or stress factors that might lower basophils, and determine whether additional differential white-cell analysis is warranted.

[ID: 16005026-de62-40ff-8a69-ae4d827204ac] Basophil Percentage [In Blood - Quantitative]

*Basophil Percentage [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: Basophil percentage shows what fraction of circulating white blood cells are basophils, cells that participate in allergy responses and help regulate immune activity. - Measurements: 0.8 % in May 2025 (reference 0.0–1.0 %); 0.9 % in November 2025 (reference 0.0–2.0 %). - Trend: Essentially stable; only a 0.1 % rise across six months and both values remain within their lab-specific normal limits. - Clinical Meaning: Levels inside the stated reference intervals suggest a balanced basophil population, implying no laboratory evidence of active allergic flare, parasitic infection, chronic inflammation, or bone-marrow overproduction during this period. The slight increase is small enough to fall within expected day-to-day variation and does not indicate a developing problem when viewed against the wider 0–2 % range reported in November. - Action: Continue routine complete blood count monitoring at the intervals recommended by your clinician; maintain current lifestyle and allergy management strategies if already in place. No additional testing or intervention is signaled by these stable, normal readings unless new symptoms arise.

[ID: 8d7c03d6-664b-485b-b73c-714c5ca2cfa5] Eosinophil Percentage [In Blood - Quantitative]

*Eosinophil Percentage [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: Eosinophil percentage reports what fraction of your white blood cells are eosinophils, the immune cells that tend to rise with allergies, asthma, certain infections, or inflammatory conditions. - Measurements: 3.0 % in July 2024, then 0.8 % in May 2025, and 1.8 % in November 2025; the laboratory reference range given for the two 2025 tests is 0.0–6.0 %. - Trend: Values have stayed within the stated reference limits, but the pattern is variable—dropping sharply from mid-range (3.0 %) to a low point (0.8 %), then partially rebounding (1.8 %); there is no clear upward or downward slope, suggesting a stable range with short-term fluctuations rather than a consistent trend. - Clinical Meaning: All three readings are in the normal interval where eosinophils typically account for only a small slice of total white cells, implying no sustained signal of allergic flare, parasitic infection, or hypereosinophilic disorders during this 16-month window; the temporary dip to 0.8 % is not usually worrisome because low eosinophil percentages rarely indicate disease and can reflect day-to-day immune variation or testing at a time when other white-cell types were relatively higher; the modest rise to 1.8 % remains well below thresholds (often >6 % or persistent absolute counts >500 cells/µL) where clinicians start to look for underlying triggers. - Action: Current numbers support that eosinophil activity is in a healthy range; keep up routine health maintenance, follow allergy or asthma management plans if you have them, and repeat the complete blood count at your provider’s recommended interval; seek medical review only if future tests exceed the upper limit or if new symptoms such as recurrent wheezing, skin rashes, sinus issues, or unexplained fatigue develop, as these could push eosinophils higher and warrant targeted evaluation.

[ID: 9486cf79-eba6-4a98-8214-b01ffe687e19] Hemoglobin [In Blood - Quantitative]

*Hemoglobin [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: Hemoglobin measures the concentration of oxygen-carrying red blood cell pigment in your blood, reflecting your blood’s capacity to deliver oxygen to tissues. - Measurements: May 2025: 14.4 g/dL; Nov 2025: 13.7 g/dL, both within the stated reference ranges (13.0–18.0 g/dL and 13.0–17.5 g/dL respectively). - Trend: Mild downward shift of 0.7 g/dL over six months (≈5 % drop); overall values remain in the normal range, indicating a generally stable but slightly declining pattern. - Clinical Meaning: Current levels still support adequate oxygen transport. The modest fall does not cross into anemia territory but could hint at evolving factors such as minor iron shortfall, occult blood loss, hydration status changes, or laboratory variation. Stability within range suggests no immediate red-flag concern, yet the downward drift is worth noticing in case it continues. - Action: Maintain balanced nutrition rich in iron, B-12, and folate; ensure adequate hydration; if fatigue, shortness of breath, or further declines are observed, discuss an interval re-test and potential iron studies with your clinician; otherwise, confirmatory testing at the next routine check is reasonable to ensure the value remains comfortably within 13.0–18.0 g/dL.

[ID: b6e1c148-73de-48d6-ad3e-469add392171] Lymphocyte Absolute Count [In Blood - Quantitative]

*Lymphocyte Absolute Count [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: The lymphocyte absolute count measures the number of lymphocytes (a type of white blood cell crucial for immune defense) circulating in each liter of blood. - Measurements: 1.5 ×10^9/L in May 2025 and 1.9 ×10^9/L in November 2025, both within the laboratory reference range of 1.5–4.5 ×10^9/L. - Trend: Improving; the count rose from the low end of normal to a mid-normal level over six months, showing a consistent upward direction without fluctuations. - Clinical Meaning: Remaining within the normal range suggests adequate immune cell availability. The initial value at the threshold could indicate a period when the immune system was operating at its minimum acceptable reserve, while the later value reflects a healthier buffer of lymphocytes, potentially translating to better readiness to fight infections or respond to immunologic challenges. No readings indicate lymphopenia (below 1.5) or lymphocytosis (above 4.5). - Action: Current values are appropriate and show positive momentum. Maintaining this trajectory can be supported by balanced nutrition, adequate sleep, stress management, and staying current on vaccinations. If future tests show a drop back to the lower limit or an unexpected spike, discussing possible causes (e.g., recent infection, medication effects) with a healthcare professional would be prudent.

[ID: 7baeed38-a16e-405f-92c3-f42df664c6e8] Lymphocyte Percentage [In Blood - Quantitative]

*Lymphocyte Percentage [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: Lymphocyte percentage reflects how much of your white-blood-cell population is made up of lymphocytes, cells that help fight infections and coordinate immune responses. - Measurements: 38.7 % in May 2025 (comfortably within the 20–45 % reference range) and 43.1 % in Nov 2025 (still within range but near the upper boundary). - Trend: Upward; the value rose by about 4.4 percentage points over six months, showing a modest, consistent increase yet remaining inside the normal limits. - Clinical Meaning: Both readings are normal, indicating a balanced immune cell distribution. The higher-normal November value could reflect a recent mild infection, allergy, or simply natural variation; isolated results at this level are not usually worrisome without accompanying symptoms or other abnormal blood counts. - Action: No immediate action is required while values stay within 20–45 %. Continue routine blood work as advised, maintain infection-preventive habits (sleep, nutrition, stress control), and report any persistent fevers, swollen glands, or unexpected fatigue to your clinician so they can decide if a follow-up blood count is needed to confirm the trend.

[ID: d17bba20-80bb-420f-95df-5dbd18ad37f2] Mean Corpuscular Hemoglobin Concentration [In Blood - Quantitative]

*Mean Corpuscular Hemoglobin Concentration [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: Mean Corpuscular Hemoglobin Concentration (MCHC) reflects the average density of hemoglobin within each red blood cell. - Measurements: 35.0 g/dL in May 2025, then 33.0 g/dL in Nov 2025; both results sit inside their stated reference ranges. - Trend: Slight downward shift of 2 g/dL over six months, but values remain comfortably normal, indicating a generally stable status with a small, non-critical decline. - Clinical Meaning: Normal readings imply red blood cells are carrying a healthy amount of hemoglobin, making iron-deficiency anemia or markedly hyperchromic conditions unlikely at these time points; the modest drop could reflect routine biological variation, minor changes in iron balance or hydration, rather than a disease process. - Action: Maintain ordinary follow-up through periodic complete blood counts; no special measures are needed while results stay within 32–36 g/dL, yet if future values fall below 32 g/dL or the downward trend accelerates, discuss iron studies, vitamin intake, and potential blood loss with your healthcare provider.

[ID: f17aba9b-fca2-4c06-a22d-9efd19155dc2] Monocyte Percentage [In Blood - Quantitative]

*Monocyte Percentage [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: Monocyte percentage tells how much of your total white blood-cell count is made up of monocytes, the immune cells that help remove damaged cells and fight infection. - Measurements: 6.8 % in July 2024, then 7.2 % in May 2025, and again 7.2 % in November 2025; the last two results sit comfortably inside the reference interval of 2.0–10.0 %. - Trend: Essentially stable; a small rise of 0.4 % between 2024 and early 2025, then unchanged over the next six months, with all recent values staying within the normal range. - Clinical Meaning: Consistently mid-range monocyte percentages suggest a balanced immune response with no evidence of the elevations often seen in acute infection, chronic inflammation, or certain blood disorders, nor the reductions linked to bone-marrow suppression; the brief 2024 “out-of-range” flag appears to reflect a missing reference range rather than a true abnormality. - Action: Current values are in the desirable zone and have remained steady for 16 months; keep usual health maintenance practices (adequate sleep, balanced diet, regular check-ups) and simply continue routine monitoring at your clinician’s recommended intervals.

[ID: 31570e84-876f-4846-9699-8b650b028fbb] Neutrophil Percentage [In Blood - Quantitative]

*Neutrophil Percentage [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: Neutrophil percentage shows what fraction of your circulating white blood cells are neutrophils, a key part of first-line immune defense. - Measurements: - Jul 2024: 42.9 % (flagged by lab but falls inside later listed reference of 40-75 %) - May 2025: 52.5 % (within 40-75 %) - Nov 2025: 47.0 % (within 40-75 %) - Trend: - Variable but overall stable; rose from 42.9 % to 52.5 %, then eased to 47.0 %. - All three results sit comfortably inside the commonly cited 40-75 % normal span, showing no sustained upward or downward drift. - Clinical Meaning: - Values in the mid-range suggest balanced white-blood-cell distribution, supporting effective response to everyday infections without signs of excessive inflammation (neutrophilia) or weakened immunity (neutropenia). - The brief peak at 52.5 % could reflect a transient immune stimulus (e.g., minor infection, stress) that resolved by the next test, which is common and not worrisome when still within range. - Consistently avoiding very low (<40 %) or very high (>75 %) percentages reduces concerns about chronic bone-marrow issues, severe infections, or inflammatory disorders. - Action: - Continue routine wellness practices—balanced diet, adequate sleep, regular exercise, and stress management—to support normal immune cell balance. - No immediate intervention needed; values are optimal. - Re-check during annual blood work or sooner if experiencing persistent infections, fevers, or unexplained fatigue.

[ID: 8a5da1be-35a8-41ab-a963-657e1f94e877] Packed Cell Volume [In Blood - Quantitative]

*Packed Cell Volume [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: Packed Cell Volume (PCV), also called hematocrit, measures the percentage of blood composed of red blood cells, reflecting oxygen-carrying capacity and hydration status. - Measurements: The PCV was 42.0 % in May 2025 and remained 42.0 % in November 2025; both readings sit comfortably within the stated laboratory reference ranges (40.0 – 54.0 % and 40.0 – 51.0 %, respectively). - Trend: Stable; there is no change between the two measurements six months apart, indicating consistency in red blood cell proportion. - Clinical Meaning: A steady PCV in the mid-normal range suggests adequate red cell mass, no evident anemia or polycythemia, and likely balanced hydration status during both tests. Because PCV can be influenced by iron status, bone marrow function, chronic diseases, or dehydration, the stable mid-normal values imply that none of these factors have shifted significantly over the period monitored. - Action: No immediate action is required based on these results alone; maintaining balanced nutrition, adequate hydration, and routine health check-ups should support continued stability. If future symptoms such as fatigue, dizziness, or unexpected changes in endurance arise, rechecking PCV alongside a full blood count would help ensure values remain optimal.

[ID: 213fa6f3-a17f-4e51-a175-fab8f914eb63] Platelet Count [In Blood - Quantitative]

*Platelet Count [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: Platelet count measures how many platelets (cells that help blood clot) are present in a given volume of blood. - Measurements: 178 ×10^9/L in Jul 2024 (two identical readings), 168 ×10^9/L in May 2025 (two identical readings), and 157 ×10^9/L in Nov 2025; all values fall within their stated reference ranges (150–410 or 150–400 ×10^9/L). - Trend: Gradual decline over the 16-month period, dropping by 21 ×10^9/L overall; although the downward movement is steady and consistent, the count remains just above the lower reference limit. - Clinical Meaning: Sustained counts inside the reference range generally indicate adequate platelet production and clotting capacity; the modest downward drift, however, suggests a slow but persistent reduction that brings the value close to the threshold where bruising or prolonged bleeding could become more likely if the trend continues. No abrupt drops were seen, making acute issues such as sudden bone-marrow suppression unlikely; instead, the pattern could reflect factors like mild nutritional deficits, chronic low-grade inflammation, or medication effects that gradually influence platelet production. - Action: Continue routine monitoring to verify whether the decline stabilizes or slips below 150 ×10^9/L; if future readings approach or fall below the lower limit, discuss with a healthcare professional about potential contributing factors (iron or B-vitamin status, medications, alcohol intake, chronic infections) and whether further testing is needed. At present levels, no immediate change is required, but maintaining a balanced diet, minimizing unnecessary alcohol or anti-inflammatory drug use, and reporting easy bruising or prolonged bleeding can help support healthy platelet levels.

[ID: 5e36d8b9-62d5-4dfc-bdf6-a95d3fc39a9d] Red Cell Distribution Width [In Blood - Quantitative]

*Red Cell Distribution Width [In Blood - Quantitative] measurements (3 data points) - Hematologic (Blood Health)*

- Overview: Red Cell Distribution Width (RDW) measures how much the sizes of your red blood cells differ from one another, reflecting the uniformity of red cell production. - Measurements: May 2025 – 13.4 % (reference < 14.3 %); November 2025 – 13.5 % (reference 12.0 – 14.8 %); both values fall comfortably inside the normal limits supplied by the labs. - Trend: A 0.1 % rise over six months points to a stable pattern; no consistent upward or downward movement is evident. - Clinical Meaning: Normal, tightly clustered RDW results suggest that your bone marrow is producing red blood cells of relatively even size, which generally rules out common problems such as iron-deficiency anemia, vitamin B12 or folate shortfall, recent significant blood loss, or certain chronic inflammatory states. The tiny increase is clinically insignificant and does not indicate emerging red cell size variability. - Action: Continue your usual balanced diet and routine check-ups; no immediate intervention is required. Include RDW in future complete blood counts so that any shift toward the upper reference limit can be detected early, at which point discussing iron, B12, and folate status with your healthcare provider would be prudent.

Your metabolic profile looks balanced: blood sugar regulation is stable, electrolytes sit comfortably in range, and uric acid levels fall in a healthy middle zone. The one value edging toward caution is Hemoglobin A1c at 5.6 %, which, although technically normal, is near the 5.7 % threshold that defines early glucose intolerance; paired with a fasting glucose of 4.4 mmol/L, it implies good day-to-day control but a slightly higher average over the past three months. Chloride at 104 mmol/L and potassium at 4.2 mmol/L align closely, reflecting intact acid–base and fluid balance, while the moderate uric acid concentration suggests no current strain on purine metabolism or kidney clearance. Taken together, these data show solid metabolic health with a single watchpoint—A1c creeping upward—which might benefit most from lifestyle fine-tuning rather than clinical intervention, especially since the glucose-A1c pairing indicates room to reinforce long-term insulin sensitivity before problems surface.

[ID: 67cd9fc2-def8-43ed-9aac-f727967a8161] Hemoglobin A1C [In Blood - Quantitative]

*Hemoglobin A1C [In Blood - Quantitative] measurements (5 data points) - Metabolic*

- Overview: Hemoglobin A1C reflects the average blood glucose level over roughly the past three months. - Measurements: - July 2024: two results taken the same month—5.5 % and 6.1 % - May 2025: 5.6 % - November 2025: 5.6 % - Trend: - Direction: improved after the single elevated 6.1 % in July 2024, then remained stable around 5.6 % through November 2025. - Consistency: three of four readings (5.5 %, 5.6 %, 5.6 %) cluster tightly, suggesting overall stability; the 6.1 % appears as an isolated higher reading rather than an ongoing rise. - Clinical Meaning: - Readings at 5.5–5.6 % are within or very near the laboratory’s “normal” reference limits (<5.7 %), indicating average glucose levels generally in the desirable range. - The isolated 6.1 % falls into the common “elevated/prediabetic” range used by many guidelines and exceeded the lab’s reference (<6.5 %), signaling that at that specific point average glucose control may have slipped. - The subsequent return to 5.6 % suggests that any upward drift was corrected, and no progressive rise has been observed over the following 16 months. - Action: - Continue whatever glucose-supportive habits (balanced diet, regular activity, weight management) helped maintain the 5.5–5.6 % results. - Keep routine A1C monitoring; if future readings approach or exceed 5.7 %, discuss strategies with a healthcare professional to prevent sustained elevation. - Maintain awareness of factors that can transiently raise A1C—illness, stress, medication changes—to interpret any future single high result in context.

[ID: 10d9aaa8-7fc9-4f62-aedb-247bfa889afe] Chloride [In Blood - Quantitative]

*Chloride [In Blood - Quantitative] measurements (3 data points) - Metabolic*

- Overview: Chloride measures the concentration of the chloride ion in your blood, an essential electrolyte that helps regulate acid-base balance, fluid movement, and nerve and muscle function. - Measurements: In May 2025 your chloride was 105 mmol/L (reference 98-109); in December 2025 it was 104 mmol/L (reference 98-107). Both readings sit comfortably inside their respective normal ranges. - Trend: Slight one-unit decrease over seven months; direction is essentially stable and well within expected day-to-day biological variation. - Clinical Meaning: Values in the mid-normal range indicate that your body is effectively maintaining electrolyte and acid-base balance. No evidence of excess chloride (hyperchloremia) or deficiency (hypochloremia) is present, suggesting adequate hydration status, kidney handling of electrolytes, and overall metabolic stability during the period measured. - Action: Continue current hydration and nutrition habits that support balanced electrolytes; no corrective action is needed based on these results alone. Maintaining regular annual chemistry panels is sufficient to confirm chloride remains in the healthy range and to watch for any future shifts related to kidney function, medications, or changes in fluid intake.

[ID: ebd5538b-e46b-451b-b248-d60b7c13d6f7] Glucose [In Blood - Quantitative]

*Glucose [In Blood - Quantitative] measurements (3 data points) - Metabolic*

- Overview: Glucose tests measure the amount of sugar circulating in your blood, a key indicator of how well the body regulates energy through insulin. - Measurements: In May 2025 the glucose level was 4.8 mmol/L; in November 2025 it was 4.4 mmol/L, both comfortably inside the reference range of 3.9–6.0 mmol/L. - Trend: Slight downward shift of 0.4 mmol/L over six months; overall pattern is stable to mildly improving, with both readings consistently normal. - Clinical Meaning: The values suggest effective blood-sugar control, indicating that the pancreas is producing enough insulin and body tissues are responding properly. Absence of elevated readings points away from pre-diabetes or diabetes, while staying above the lower reference limit avoids concerns about reactive hypoglycemia. The small reduction could reflect beneficial lifestyle factors such as balanced diet, regular activity, or weight management. - Action: Continue current habits that support healthy glucose regulation—regular meals with complex carbohydrates, adequate protein and fiber, physical activity, and weight maintenance. Keep scheduled monitoring as advised by your healthcare provider to confirm ongoing stability, especially if medications, diet, or activity levels change.

[ID: b50d535e-abe8-4032-bec7-33462067e75a] Potassium [In Blood - Quantitative]

*Potassium [In Blood - Quantitative] measurements (3 data points) - Metabolic*

- Overview: Potassium measures the concentration of this essential electrolyte that supports nerve signaling, muscle contraction, and heart rhythm. - Measurements: Two tests taken in May 2025 and December 2025 each showed a potassium level of 4.2 mmol/L, falling squarely within the laboratory reference range of 3.5 – 5.1 mmol/L. - Trend: The readings are identical, indicating a stable pattern with no upward or downward drift during the seven-month interval. - Clinical Meaning: A consistent mid-normal potassium level suggests effective regulation by the kidneys, balanced dietary intake, and an absence of factors that commonly disturb potassium (such as certain medications, dehydration, or metabolic disorders). Stable potassium is favorable for maintaining steady heartbeat and muscle function, and it lowers the likelihood of complications like arrhythmias or muscle weakness that arise when levels move outside the normal range. - Action: Maintain current habits that support potassium balance—adequate hydration, a varied diet that includes fruits and vegetables, and adherence to any medication plan your clinician has set. If new medications, significant dietary changes, or illnesses occur, a follow-up potassium test may be useful to confirm continued stability.

[ID: 210b2cd7-1806-44cf-aefc-ce6b641e3d30] Uric Acid [In Blood - Quantitative]

*Uric Acid [In Blood - Quantitative] measurements (3 data points) - Metabolic*

- Overview: Uric Acid measures the concentration of uric acid in the blood, a waste product from purine breakdown that is filtered by the kidneys. - Measurements: 0.28 mmol/L in May 2025 and 0.27 mmol/L in December 2025, both within the laboratory reference range of 0.22–0.55 mmol/L. - Trend: Essentially stable; a minimal decrease of 0.01 mmol/L over seven months shows no meaningful upward or downward drift. - Clinical Meaning: Values consistently inside the normal range indicate balanced purine metabolism and effective kidney excretion, suggesting low current risk for conditions linked to high uric acid such as gout or uric acid kidney stones. The results are not below the lower limit, so overly low uric acid–related concerns (rare and usually benign) are also unlikely. - Action: Continue whatever lifestyle practices are supporting these healthy levels—adequate hydration, balanced diet, and weight management—while following routine check-ups; no immediate changes are required based on these readings alone.

Inflammatory markers paint a mixed picture: erythrocyte sedimentation rate is low-normal at 5 mm/hr and high-sensitivity CRP is below 0.50 mg/L, both pointing to minimal current systemic inflammation, yet rheumatoid factor sits above the reference range at 18 IU/mL, signalling an immunologic antibody that can precede or accompany autoimmune joint disease even when acute-phase reactants are quiet. The standout abnormal value is the elevated rheumatoid factor, whereas the notably favourable result is the total-cholesterol/HDL ratio of 2.2, well inside the cardioprotective zone. Seen together, the absence of raised ESR and hsCRP alongside a high rheumatoid factor suggests an underlying autoimmune signal without overt inflammatory flare, highlighting that antibody production can occur independently of active inflammation and may remain clinically silent for some time. Clinically, this constellation urges attention to musculoskeletal symptoms rather than cardiovascular risk, as lipid balance is reassuring while immune activation appears the dominant outlier.

[ID: e20770bc-43ef-44e7-84e3-c97b91a39ccb] Rheumatoid Factor [In Blood - Quantitative]

*Rheumatoid Factor [In Blood - Quantitative] measurements (3 data points) - Immune/Autoimmune*

- Overview: Rheumatoid Factor (RF) measures a blood antibody whose presence in higher-than-normal amounts can reflect ongoing autoimmune activity, most famously rheumatoid arthritis. - Measurements: 23.0 IU/mL in Jul 2024 (lab reference <20.0); 19.9 IU/mL in May 2025 (lab reference <14.0); 18.0 IU/mL in Nov 2025 (lab reference <14.0). - Trend: Values have fallen steadily over 16 months (23 → 19.9 → 18 IU/mL). Although trending down, each reading remains above its laboratory’s upper limit, so the pattern is improving but still abnormal. - Clinical Meaning: • The consistent yet modest decrease suggests a reduction in autoimmune antibody load or better disease control over time. • Because all results exceed each lab’s reference range, some autoimmune activity likely persists. • The different reference limits show that even small numerical changes can be clinically meaningful; the most recent value (18 IU/mL) would have been “normal” in the first lab but is still elevated in the current lab’s stricter range, underscoring the importance of using the same laboratory for precise trend comparison. • Persistently elevated RF does not confirm an active disease flare on its own but can correlate with joint inflammation, fatigue, or other rheumatoid-related symptoms if present. - Action: • Continue regular monitoring with the same laboratory when possible to track whether the downward trend persists and eventually falls inside the reference range. • Share these results with your healthcare provider, especially if you notice joint pain, swelling, or stiffness, as adjustments in therapy or further tests (e.g., anti-CCP, inflammatory markers) may be warranted. • If you are already on treatment, the declining RF supports current management effectiveness, but staying above the threshold suggests room for further optimization. • Maintain lifestyle measures that lower systemic inflammation (balanced diet, regular low-impact exercise, stress management) unless contraindicated, and ensure timely follow-up testing as recommended.

[ID: 68d2ce85-b692-4c10-aa9b-7c8a4e8936ea] Erythrocyte Sedimentation Rate [In Blood - Quantitative]

*Erythrocyte Sedimentation Rate [In Blood - Quantitative] measurements (3 data points) - Inflammatory*

- Overview: The erythrocyte sedimentation rate (ESR) measures how quickly red blood cells settle in a tube of blood, serving as a general indicator of inflammation anywhere in the body. - Measurements: - July 2024: two identical readings of 2 mm/hr (reference 0-20 mm/hr) - May 2025: 5 mm/hr (reference <31 mm/hr) - November 2025: 5 mm/hr (reference 0-10 mm/hr) - Trend: - Direction: slight rise from 2 mm/hr to 5 mm/hr between mid-2024 and mid-2025, then stable at 5 mm/hr for the next six months. - Consistency: all four results remained well inside their respective normal ranges; no spikes or erratic changes observed. - Clinical Meaning: - Values of 2-5 mm/hr are considered low and typically indicate minimal to no systemic inflammation. - The small increase of 3 mm/hr over ten months is minor and still below thresholds commonly associated with infection, autoimmune flare, or chronic inflammatory conditions. - Stability at 5 mm/hr for two tests six months apart suggests the earlier rise was likely a normal variation rather than an evolving inflammatory process. - Since ESR is nonspecific, an isolated normal result does not rule out every condition, but the consistently low levels point toward an overall low inflammatory burden during the period measured. - Action: - Current values are optimal; no action is required solely based on ESR. - Continue routine health maintenance and repeat ESR only if new symptoms (e.g., persistent fatigue, unexplained fever, joint pain) arise, as these could warrant re-evaluation. - If other lab tests or clinical findings ever suggest inflammation, trending ESR alongside more specific markers (such as C-reactive protein) can provide a broader picture.

[ID: 14dbfb69-15e0-45d2-8c70-d570646db98e] High Sensitivity C-Reactive Protein [In Blood - Quantitative]

*High Sensitivity C-Reactive Protein [In Blood - Quantitative] measurements (3 data points) - Inflammatory*

- Overview: High-sensitivity C-reactive protein (hs-CRP) detects very small amounts of CRP in the blood, serving as a marker of overall body inflammation. - Measurements: In July 2024 the value was 0.5 mg/L; in May 2025 the laboratory reported “< 0.50 mg/L,” indicating the result was below the 0.5 mg/L threshold. Both readings fall well within the laboratory’s reference interval of 0.0 – 5.0 mg/L. - Trend: The two consecutive results show a slight decrease from 0.5 mg/L to a value below that level, suggesting an improving and consistently low inflammatory status over the 10-month period. - Clinical Meaning: Sustained hs-CRP values at or below 0.5 mg/L typically reflect minimal systemic inflammation. Low inflammation is generally linked to reduced risk for cardiovascular conditions and other inflammation-related disorders. Because both readings are markedly lower than the upper reference limit, they reinforce the impression of a healthy inflammatory profile during the period measured. - Action: No red flags appear in the data. Continue the habits—balanced diet, regular physical activity, weight management, and adequate sleep—that likely support this low inflammatory state. Routine hs-CRP checks at intervals recommended by the healthcare team can confirm that levels stay in this favorable range, especially if new symptoms or risk factors arise.

[ID: 9eb16fb3-55e6-411f-ae54-65524d6ff623] Total Cholesterol To High Density Lipoprotein Cholesterol Ratio [In Serum - Quantitative]

*Total Cholesterol To High Density Lipoprotein Cholesterol Ratio [In Serum - Quantitative] measurements (3 data points) - Lipid*

- Overview: This ratio compares the amount of total cholesterol to HDL (“good”) cholesterol, giving a quick snapshot of heart and blood-vessel risk—the lower the number, the more favorable. - Measurements: Three identical readings of 3.82 in July 2024, followed by 2.4 in May 2025 and 2.2 in November 2025. - Trend: Steady improvement; the ratio fell sharply between 2024 and 2025 and remained in a healthy range on the two most recent checks, showing a consistent downward (better) direction. - Clinical Meaning: A ratio above about 3.5–5.0 is often linked to higher cardiovascular risk; your July 2024 value of 3.82 suggested elevated risk. The subsequent ratios of 2.4 and 2.2 fall well below typical risk thresholds, indicating a much more favorable balance between “bad” and “good” cholesterol and a likely reduction in long-term heart-disease risk. - Action: Continue whatever changes led to the improvement—common contributors include increased physical activity, weight control, higher intake of healthy fats (e.g., nuts, olive oil), reduced refined carbs, and avoidance of smoking. Keep monitoring annually; aim to keep the ratio below about 3.0. If lifestyle habits change or if future results rise again, consider re-evaluating diet, exercise, and, if advised by your clinician, medication options.

Your kidney profile appears generally healthy: blood creatinine sits within the laboratory range, and both urine concentrating ability (specific gravity) and urine acid-base balance (pH) fall comfortably in the expected intervals, pointing to preserved filtration and tubular function. The value that draws most attention is creatinine at 109 µmol/L—still normal but close to the upper limit—whereas specific gravity of 1.015 and urine pH of 6.5 are solidly mid-range, indicating neither marked dehydration nor unusual dietary acid load. Looking at these markers together, a near-high creatinine combined with ordinary urine concentration hints that the kidneys are clearing waste effectively despite a slightly heavier creatinine burden, which could stem from higher muscle mass or recent protein intake rather than impaired function. Taken as a set, the numbers depict kidneys that are working well, yet the closeness of creatinine to its threshold makes it the parameter worth watching at future check-ups; maintaining steady hydration will help clarify whether this borderline elevation reflects physiology or a developing trend.

[ID: 9289b8d2-8e54-4b22-9f6f-3a1a81cfc5aa] Creatinine [In Blood - Quantitative]

*Creatinine [In Blood - Quantitative] measurements (3 data points) - Kidney Function*

- Overview: Creatinine reflects how well the kidneys are filtering waste products from the blood. - Measurements: Four identical readings of 96 µmol/L were recorded in July 2024; a single later reading of 109 µmol/L was taken in December 2025. All results remained within their stated laboratory reference ranges. - Trend: After a period of stability at 96 µmol/L, the value rose modestly to 109 µmol/L 17 months later; overall direction is mildly upward but still inside normal limits. - Clinical Meaning: The kidneys continue to function within the laboratory’s accepted range, yet the 13 µmol/L increase places the most recent value nearer the upper boundary. Such a rise can sometimes signal early changes in kidney filtration efficiency, especially if the upward drift continues, but isolated results within range do not necessarily imply disease. Hydration status, muscle mass, and certain medications can also influence creatinine. - Action: No immediate concern is evident, but consider repeating the test in 6–12 months to confirm that the value is not trending higher. Maintain good hydration, review any medications or supplements that might affect kidney function with a clinician, and support renal health through balanced blood pressure, blood sugar, and protein intake.

[ID: 05568907-8519-49ee-966e-a285bbecd753] Ph [In Urine - Quantitative]

*Ph [In Urine - Quantitative] measurements (3 data points) - Kidney Function*

- Overview: The urine pH test measures how acidic or alkaline the urine is, reflecting the body’s acid–base balance and factors such as diet, hydration, and certain metabolic or kidney conditions. - Measurements: 7.0 in Jul 2024 (flagged out of range by that lab), two identical 7.5 readings in May 2025 (within the stated 5.0–8.0 reference), and 6.5 in Nov 2025 (within the 4.8–8.4 reference). - Trend: Values shifted from neutral-alkaline (7.0) to clearly alkaline (7.5) and then moved toward mild acidity/near-neutral (6.5); overall pattern is variable rather than steadily up or down. - Clinical Meaning: All results fall inside the broad clinical norm of 4.5–8.0, suggesting kidney acid–base handling is generally adequate. The brief rise to 7.5 could reflect a temporary influence—such as a plant-rich diet, antacid use, or mild urinary tract colonization—while the later 6.5 indicates a return toward typical mid-range pH. No single reading signals disease, but persistent values above 8.0 can accompany urinary infections or certain metabolic states, and values below 5.0 can point to systemic acidosis or high-protein intake. - Action: Continue balanced nutrition and good hydration, as these support a mid-range urine pH. Repeat testing is reasonable during routine check-ups; seek medical review sooner if future values rise above 8.0, fall below 5.0, or if urinary symptoms (burning, frequency, cloudy urine) develop, because such changes can warrant evaluation for infection, stones, or metabolic issues.

[ID: 887c9f5d-fedd-46ce-b21a-f66f4e5fc37e] Specific Gravity [In Urine - Quantitative]

*Specific Gravity [In Urine - Quantitative] measurements (3 data points) - Kidney Function*

- Overview: Specific gravity in urine reflects how concentrated the urine is compared with water, offering insight into hydration status and the kidneys’ ability to concentrate or dilute urine. - Measurements: Two readings over six months show 1.007 in May 2025 and 1.015 in November 2025, both within the laboratory reference range of 1.005–1.030. - Trend: Slight upward movement from low-normal toward mid-normal; with only two points, the pattern looks mildly improving and internally consistent rather than variable. - Clinical Meaning: A value near the lower end (1.007) often appears when fluid intake is high or urine is very dilute, while a mid-range value (1.015) generally indicates balanced hydration and normal kidney concentrating ability; the shift suggests the kidneys are effectively modulating urine concentration and overall fluid balance is adequate. - Action: Continue current hydration habits, aiming for steady fluid intake that avoids excessive dilution yet prevents dehydration; no immediate changes are required but repeating the test at routine intervals can confirm the upward trend remains in the healthy mid-range.

Report Settings

Configuration

User ID	38c83383-788f-433b-8683-b6df2bd2fda6
Report ID	test-chr-001
Filename	test-report.pdf
Version	1.0.0
Model	gpt-5-mini
Temperature	0.2
Language	en
Data Types	biomarkers,demographics

Data Metrics

Enabled Types: biomarkers,demographics

Biomarkers	7,016 records (559 unique)
Date Range	1999-01-01 to 2025-12-01

Processing Metrics

Setup Phase	14ms
Outline Phase	7.8s
Report Phase	32.7s
Total Runtime	40.5s